Alnylam Pharmaceuticals Inc (ALNY)

124.23 +2.25  +1.84% NASDAQ Dec 5, 20:00 Delayed 2m USD

Alnylam Pharmaceuticals Revenue (TTM):

169.10M for Sept. 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Revenue (TTM) Chart

Export Data
Save Image
Print Image

Historical Revenue (TTM) Data

View and export this data going back to 2003. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2019 169.10M
June 30, 2019 101.11M
March 31, 2019 86.30M
Dec. 31, 2018 74.91M
Sept. 30, 2018 91.80M
June 30, 2018 106.83M
March 31, 2018 92.85M
Dec. 31, 2017 89.91M
Sept. 30, 2017 69.44M
June 30, 2017 66.00M
March 31, 2017 58.77M
Dec. 31, 2016 47.16M
Sept. 30, 2016 37.26M
June 30, 2016 29.93M
March 31, 2016 29.90M
Dec. 31, 2015 41.10M
Sept. 30, 2015 57.56M
June 30, 2015 62.21M
March 31, 2015 60.82M
Dec. 31, 2014 50.56M
Sept. 30, 2014 37.39M
June 30, 2014 35.41M
March 31, 2014 36.80M
Dec. 31, 2013 47.17M
Sept. 30, 2013 44.82M
   
June 30, 2013 52.58M
March 31, 2013 64.78M
Dec. 31, 2012 66.72M
Sept. 30, 2012 78.68M
June 30, 2012 82.72M
March 31, 2012 82.45M
Dec. 31, 2011 82.76M
Sept. 30, 2011 83.49M
June 30, 2011 90.37M
March 31, 2011 96.37M
Dec. 31, 2010 100.04M
Sept. 30, 2010 105.48M
June 30, 2010 102.06M
March 31, 2010 100.04M
Dec. 31, 2009 100.53M
Sept. 30, 2009 98.31M
June 30, 2009 99.80M
March 31, 2009 99.03M
Dec. 31, 2008 96.16M
Sept. 30, 2008 89.99M
June 30, 2008 80.57M
March 31, 2008 65.87M
Dec. 31, 2007 50.90M
Sept. 30, 2007 39.65M
June 30, 2007 31.54M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More

Advertisement

Revenue (TTM) Benchmarks

Benchmarks
The Medicines Co --
Amgen Inc 23.40B
Regeneron Pharmaceuticals Inc 7.622B

Revenue (TTM) Range, Past 5 Years

Minimum 29.90M Mar 2016
Maximum 169.10M Sep 2019
Average 71.18M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.